Navigation Links
American Society of Clinical Oncology issues annual report on progress against cancer
Date:12/5/2011

ALEXANDRIA, Va. The American Society of Clinical Oncology (ASCO) today released Clinical Cancer Advances 2011: ASCO's Annual Report on Progress Against Cancer, an independent review of the advances in cancer research that have had the greatest impact on patient care this year. The report also identifies the most promising trends in oncology and provides insights from experts on where the future of cancer care is heading.

"We've made significant strides in clinical cancer research over the past year and this report adds renewed hope for patients," said Nicholas J. Vogelzang, MD, Co-Executive Editor of the report. "More personalized treatment approaches and advances in early detection are helping patients live longer, healthier lives. But we must improve the nation's clinical research system and expand access to quality cancer care to accelerate the pace of progress."

This year's top research advances demonstrate new therapies for reducing cancer recurrence, progress made against hard-to-treat cancers, and improvements in cancer prevention and screening. The report also highlights several new drug approvals that bring smarter, more effective therapies to specific genetic subgroups of patients with cancer. The top five advances selected by the editors are:

  • A Phase III study finding that vemurafenib (Zelboraf), which targets a common mutation in melanoma in a gene called BRAF, improved overall survival in patients with advanced melanoma when compared to standard chemotherapy

  • A large national screening trial of more than 50,000 current and former heavy smokers that found three annual low-dose computed tomography (CT) scans reduced the death rate from lung cancer by 20 percent compared to those who were screened with three annual chest X-rays

  • FDA approvals on therapies for two hard-to-treat cancers:
    1. Crizotinib (Xalkori) was approved for patients with advanced non-small-cell lung cancer who harbor a specific type of alteration in the anaplastic lymphoma kinase (ALK) gene based on the results from two Phase II studies: one study demonstrated that 50 percent of patients experienced complete or partial tumor shrinkage for a median of 10 months and a second study found a 61 percent objective response rate lasting a median of 12 months
    2. Ipilimumab (Yervoy) an immune therapy that activates the immune system's T cells was approved for patients with previously untreated metastatic melanoma based on the results of a Phase III trial showing that the drug, combined with the standard chemotherapy drug dacarbazine, improved overall survival by two months

  • The first conclusive evidence that an aromatase inhibitor reduced the risk of a first breast cancer, making exemestane (Aromasin) a preventative treatment option for postmenopausal women who are at high risk for the disease.

Selected by an 18-person editorial board of prominent oncologists, the report highlights a total of 54 advances in clinical oncology over the past year and covers the full scope of patient care, including cancer disparities, advanced cancer care and survivor care. Clinical Cancer Advances 2011 also features a "Year in Review" section, which describes key cancer policy developments and ASCO policy initiatives from the past year that are likely to influence cancer care over the coming years. Some of the important topics covered in this section include:


'/>"/>

Contact: Susie Tappouni
susie.tappouni@asco.org
571-483-1355
American Society of Clinical Oncology
Source:Eurekalert

Related medicine news :

1. American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time
2. Satellite Healthcares Sheila Doss Elected Western Chapters Coordinator-Elect of the American Nephrology Nurses Association
3. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
4. Highmark Foundation Awards $120,000 to the American Heart Association
5. American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women
6. New American Heart Association Survey Finds Heart Disease and Stroke Patients Face Significant Barriers in Obtaining Quality, Affordable Care
7. American Heart Association Comment on Hospitalization of President Bill Clinton
8. Majority of Americans Approve of President Obamas Handling of Afghanistan and National Security But Disapprove of Handling of Economic Issues, Per Franklin & Marshall College Poll With Hearst Television
9. American Red Cross Issues One-Month Progress Report for Haiti Earthquake
10. 57 Million Americans Sickened by H1N1 Flu: CDC
11. Concentra, American Showa to Open Associates Health Center in Blanchester, Ohio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... National recruitment firm ... life sciences executive with extensive sequencing and genomics experience, as Vice President of North ... Ms. Hill will be responsible for leading the sales team in the commercialization of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
Breaking Medicine Technology: